Immersive Virtual Reality for Chronic Neuropathic Pain After Spinal Cord Injury: A Feasibility Trial
CompletedNot applicableNCT04700033
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study is to provide critical information about the efficacy of Immersive Virtual Reality (IVR) to decrease the experience of neuropathic pain in the upper and lower extremities of people with a spinal cord injury.
Study details
- Official title
- Immersive Virtual Reality for Chronic Neuropathic Pain After Spinal Cord Injury: A Feasibility Trial
- Interventions
- Device: Somatic IVR (sIVR)
- Device: Distractive IVR (dIVR)
- Device: Control IVR (cIVR)
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start date
- 2019-07-17
- Primary completion
- 2022-05-05
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Spinal cord injury survivors (chronic only) * Presence of neuropathic pain at or below SCI level for at least 6 months following trauma or disease of the spinal cord * A pain intensity of at least 2 out of 10 in the numerical pain rating scale (NPRS) test at baseline * Stable pharmacological treatment for at least 4 weeks prior to the study and throughout the trial Exclusion Criteria: * Psychiatric or other neurological disorders (Participants will not be excluded for having a SCI, if they score 0-30 points on the BDI, or if they report having anxiety) * Head injuries causing cognitive or visual impairment * Severe vertigo
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04700033